Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Sep;45(3):537–543. doi: 10.1128/iai.45.3.537-543.1984

Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

A S Kreger, L D Gray, J Testa
PMCID: PMC263326  PMID: 6469346

Abstract

Vaccination of mice with either Formalin-killed cells or cell extracts of a virulent strain and a weakly virulent strain of Vibrio vulnificus or with rabbit antisera (AS) against the Formalin-killed cells and cell extracts protected against the virulent strain of V. vulnificus. However, the virulent strain vaccines and AS elicited a significantly stronger immune response than the weakly virulent strain vaccines and AS. Adsorption of the AS with either the homologous or heterologous Formalin-killed cells significantly reduced the ability of the AS to protect mice. The major protective antigen(s) in the cell extracts migrated in the void volume of Sephacryl S-400 superfine, was not effectively sedimented by centrifugation at 100,000 X g for 2 h, had an isoelectric point of 3.8 to 4.2, and was sensitive to boiling or autoclaving for 15 min, periodate oxidation, and exposure to pH 12 but was resistant to 56 degrees C, trypsin, pronase, RNase, neuraminidase, and pH 4.5. Electron microscopy revealed that the virulent strain possessed a more dense ruthenium red-staining layer on its outer membrane and had a much smoother surface than the weakly virulent strain. Our results provide evidence that a major protective antigen and virulence factor of V. vulnificus is a heat-labile, acidic polysaccharide located on the bacterial surface.

Full text

PDF
537

Images in this article

541Image
on p.541

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckman E. N., Leonard G. L., Castillo L. E., Genre C. F., Pankey G. A. Histopathology of marine vibrio wound infections. Am J Clin Pathol. 1981 Dec;76(6):765–772. doi: 10.1093/ajcp/76.6.765. [DOI] [PubMed] [Google Scholar]
  2. Blake P. A., Weaver R. E., Hollis D. G. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341–367. doi: 10.1146/annurev.mi.34.100180.002013. [DOI] [PubMed] [Google Scholar]
  3. Bonner J. R., Coker A. S., Berryman C. R., Pollock H. M. Spectrum of Vibrio infections in a Gulf Coast community. Ann Intern Med. 1983 Oct;99(4):464–469. doi: 10.7326/0003-4819-99-4-464. [DOI] [PubMed] [Google Scholar]
  4. Bowdre J. H., Poole M. D., Oliver J. D. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun. 1981 Jun;32(3):1193–1199. doi: 10.1128/iai.32.3.1193-1199.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carruthers M. M., Kabat W. J. Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum. Infect Immun. 1981 May;32(2):964–966. doi: 10.1128/iai.32.2.964-966.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Castillo L. E., Winslow D. L., Pankey G. A. Wound infection and septic shock due to Vibrio vulnificus. Am J Trop Med Hyg. 1981 Jul;30(4):844–848. doi: 10.4269/ajtmh.1981.30.844. [DOI] [PubMed] [Google Scholar]
  7. Craig D. B., Stevens D. L. Halophilic Vibrio sepsis. South Med J. 1980 Sep;73(9):1285–1287. doi: 10.1097/00007611-198009000-00048. [DOI] [PubMed] [Google Scholar]
  8. Farmer J. J., 3rd Vibrio ("Beneckea") vulnificus, the bacterium associated with sepsis, septicaemia, and the sea. Lancet. 1979 Oct 27;2(8148):903–903. doi: 10.1016/s0140-6736(79)92715-6. [DOI] [PubMed] [Google Scholar]
  9. Flesher A. R., Jennings H. J., Lugowski C., Kasper D. L. Isolation of a serogroup 1-specific antigen from Legionella pneumophila. J Infect Dis. 1982 Feb;145(2):224–233. doi: 10.1093/infdis/145.2.224. [DOI] [PubMed] [Google Scholar]
  10. Ghosh H. K., Bowen T. E. Halophilic vibrios from human tissue infections on the pacific coast of Australia. Pathology. 1980 Jul;12(3):397–402. doi: 10.3109/00313028009077102. [DOI] [PubMed] [Google Scholar]
  11. Hollis D. G., Weaver R. E., Baker C. N., Thornsberry C. Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol. 1976 Apr;3(4):425–431. doi: 10.1128/jcm.3.4.425-431.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnston J. M., Andes W. A., Glasser G. Vibrio vulnificus. A gastronomic hazard. JAMA. 1983 Apr 1;249(13):1756–1757. [PubMed] [Google Scholar]
  13. Kasper D. L., Onderdonk A. B., Reinap B. G., Linberg A. A. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen. J Infect Dis. 1980 Nov;142(5):750–756. doi: 10.1093/infdis/142.5.750. [DOI] [PubMed] [Google Scholar]
  14. Kelly M. T., McCormick W. F. Acute bacterial myositis caused by Vibrio vulnificus. JAMA. 1981 Jul 3;246(1):72–73. [PubMed] [Google Scholar]
  15. Kreger A., DeChatelet L., Shirley P. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis. J Infect Dis. 1981 Sep;144(3):244–248. doi: 10.1093/infdis/144.3.244. [DOI] [PubMed] [Google Scholar]
  16. Kreger A., Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun. 1981 Aug;33(2):583–590. doi: 10.1128/iai.33.2.583-590.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Matsuo T., Kohno S., Ikeda T., Saruwatari K., Ninomiya H. Fulminating lactose-positive Vibrio septicemia. Acta Pathol Jpn. 1978 Nov;28(6):937–948. doi: 10.1111/j.1440-1827.1978.tb01282.x. [DOI] [PubMed] [Google Scholar]
  18. Mertens A., Nagler J., Hansen W., Gepts-Friedenreich E. Halophilic, lactose-positive Vibrio in a case of fatal septicemia. J Clin Microbiol. 1979 Feb;9(2):233–235. doi: 10.1128/jcm.9.2.233-235.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pollak S. J., Parrish E. F., 3rd, Barrett T. J., Dretler R., Morris J. G., Jr Vibrio vulnificus septicemia. Isolation of organism from stool and demonstration of antibodies by indirect immunofluorescence. Arch Intern Med. 1983 Apr;143(4):837–838. doi: 10.1001/archinte.143.4.837. [DOI] [PubMed] [Google Scholar]
  20. Poole M. D., Oliver J. D. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun. 1978 Apr;20(1):126–129. doi: 10.1128/iai.20.1.126-129.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SPIRO R. G. PERIODATE OXIDATION OF THE GLYCOPROTEIN FETUIN. J Biol Chem. 1964 Feb;239:567–573. [PubMed] [Google Scholar]
  22. Simon G. L., Klempner M. S., Kasper D. L., Gorbach S. L. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan;145(1):72–77. doi: 10.1093/infdis/145.1.72. [DOI] [PubMed] [Google Scholar]
  23. Simpson L. M., Oliver J. D. Siderophore production by Vibrio vulnificus. Infect Immun. 1983 Aug;41(2):644–649. doi: 10.1128/iai.41.2.644-649.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith G. C., Merkel J. R. Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun. 1982 Mar;35(3):1155–1156. doi: 10.1128/iai.35.3.1155-1156.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tacket C. O., Barrett T. J., Mann J. M., Roberts M. A., Blake P. A. Wound infections caused by Vibrio vulnificus, a marine vibrio, in inland areas of the United States. J Clin Microbiol. 1984 Feb;19(2):197–199. doi: 10.1128/jcm.19.2.197-199.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wickboldt L. G., Sanders C. V. Vibrio vulnificus infection. Case report and update since 1970. J Am Acad Dermatol. 1983 Aug;9(2):243–251. doi: 10.1016/s0190-9622(83)80357-0. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES